305 related articles for article (PubMed ID: 15485095)
1. Antiphospholipid antibodies as cause of pregnancy loss.
Meroni PL; di Simone N; Testoni C; D'Asta M; Acaia B; Caruso A
Lupus; 2004; 13(9):649-52. PubMed ID: 15485095
[TBL] [Abstract][Full Text] [Related]
2. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss.
Meroni PL; Gerosa M; Raschi E; Scurati S; Grossi C; Borghi MO
Clin Rev Allergy Immunol; 2008 Jun; 34(3):332-7. PubMed ID: 18175073
[TBL] [Abstract][Full Text] [Related]
3. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view.
Meroni PL; Tedesco F; Locati M; Vecchi A; Di Simone N; Acaia B; Pierangeli SS; Borghi MO
Lupus; 2010 Apr; 19(4):453-6. PubMed ID: 20353987
[TBL] [Abstract][Full Text] [Related]
4. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature.
Di Simone N; Luigi MP; Marco D; Fiorella DN; Silvia D; Clara DM; Alessandro C
Ann N Y Acad Sci; 2007 Jun; 1108():505-14. PubMed ID: 17894016
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
Cervera R; Espinosa G
Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
[TBL] [Abstract][Full Text] [Related]
8. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH
J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
Pelusa HF; Pezzarini E; Basiglio CL; Musuruana J; Bearzotti M; Svetaz MJ; Daniele SM; Bottai H; Arriaga SM
Ann Clin Biochem; 2017 Sep; 54(5):577-583. PubMed ID: 27638930
[TBL] [Abstract][Full Text] [Related]
12. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.
Tincani A; Bazzani C; Zingarelli S; Lojacono A
Semin Thromb Hemost; 2008 Apr; 34(3):267-73. PubMed ID: 18720306
[TBL] [Abstract][Full Text] [Related]
13. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid syndrome and pregnancy].
Koleva R; Chernev T; Karag'ozova Zh; Dimitrova V
Akush Ginekol (Sofiia); 2004; 43(1):36-42. PubMed ID: 15168653
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
Lee RM; Emlen W; Scott JR; Branch DW; Silver RM
Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Asherson RA; Cervera R; Merrill JT; Erkan D
Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
[TBL] [Abstract][Full Text] [Related]
18. New autoantigens in the antiphospholipid syndrome.
Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G
Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of anti-phospholipid antibody formation and action.
de Groot PG
Thromb Res; 2011 Feb; 127 Suppl 3():S40-2. PubMed ID: 21262437
[TBL] [Abstract][Full Text] [Related]
20. [Antiphospholipid antibodies in practice].
Miyara M; Diemert MC; Amoura Z; Musset L
Rev Med Interne; 2012 Apr; 33(4):176-80. PubMed ID: 22100197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
